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It is difficult to willingly forget
about DNA — what it looks like,
how it works, what you can do
with it, and what it means as a
unifying idea. It’s tricky, but it’s
what would be required to look
over Avery’s shoulder in 1943 as
he wrote up his paper on the
‘transforming principle’. For
authenticity’s sake, you could
throw in a certain preoccupation
with proteins and their
fascinating diversity, and an
understanding of DNA as an
uncomplicated chemical
constituent of the nucleus. At that
point, you’d probably be
sufficiently skeptical.
The work reported in February
of 1944 by Oswald Avery, Colin
MacLeod and Maclyn McCarty
has been called the century’s
greatest biological discovery, but
also the ‘undiscovered discovery’.
It broke the seal on modern
biology, but famously failed to win
a Nobel prize. It showed that DNA
possessed genetic information
that could transform the heritable
character of cells, but the world of
biological research in 1944 had
enough in the way of distractions,
assumptions, and divisions to
withhold its attention from such a
revolutionary idea.
In some ways, the story wasn’t
all that new, having begun with a
paper sixteen years before. As an
officer of Britain’s Ministry of
Health, the bacteriologist Fred
Griffith had in 1928 published the
outcome of his latest efforts at
characterizing the puzzle of
serological types present among
pneumococci. Samples collected
from pneumonia patients routinely
yielded multiple pneumococcal
types representing various
subsets of the known serological
categories. The basis for this
phenomenon, and its clinical
relevance, were unclear to
medical bacteriologists.
Pneumonia was a leading killer
of the day, but bacteriologists had
few tools with which to study the
cell biology and virulence of the
organism responsible. Armed with
sputum samples, chocolate blood
media plates and an assortment of
type-specific sera, Griffith set
about characterizing the
pneumococcal types present from
samples collected at various points
during illness, using sequential
antibody neutralization and
inoculation into mice as an assay.
Critically, though perhaps
surprisingly, he did not assume as
an explanation for the type results
an etiology of multiple infection,
and pursued experiments testing
the possibility of in vivo type-
switching. In doing so, he
succeeded in demonstrating that
type transformation could occur in
mice. Subcutaneous inoculation of
a mixture of live — but avirulent —
pneumococci of a first serotype,
and heat-killed, virulent cells of a
second serotype led to virulent
disease in an injected mouse;
moreover, he subsequently
isolated virulent cells of the second
serological type. As is apparent in
his discussion of the work,
Griffith’s concerns lay with the
clinical treatment of pneumonia,
not the chemical nature of the
transformation. Besides, as
McCarty points out in his excellent
book, The Transforming Principle,
at that time ‘bacteriology had
developed as a science almost as
if unrelated to the rest of biology. It
was too early in its history to
expect genetic interpretations of
any phenomena encountered in the
laboratory’.
Avery was at that time involved
in characterizing the antigenic
nature of the pneumococcal
capsule, working at what was then
the Hospital of the Rockefeller
Institute for Medical Research.
Upon seeing Griffith’s paper he
was reportedly intrigued but not
wholly convinced by the findings,
at least until they were confirmed
shortly afterwards by Fred Neufeld
working at the Koch Institute in
Berlin. At about the time Griffith’s
study appeared, it so happened
that one of Avery’s associates,
Martin Dawson, was writing up his
own observations regarding
pneumococcal transformation.
Griffith had attempted to
demonstrate the transforming
effect in vitro but had failed;
Dawson saw an opportunity and
succeeded with Richard Sia in
recapitulating in vitro the virulence
switching he’d seen in mice. With a
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The transformation: This plate from Avery’s 1944 paper shows the dramatic change
associated with transformation from ‘rough’ (and avirulent) type II cells (left), to ‘smooth’,
virulent type III cells (right). (Reproduced from The Journal of Experimental Medicine,
1944; 79:137-158, by copyright permission of The Rockefeller University Press.)
test-tube assay in hand, Avery’s
group had the stage set for a
concerted biochemical analysis of
the transformation phenomenon,
but the ensuing story took nearly
14 years to play out. Most years
brought their share of important
steps forward, but a few saw
almost no progress. There was a
significant lull around 1934 when
Avery underwent thyroid surgery
for the treatment of Graves’
disease, and another hiatus in the
late thirties during which the
project was put aside for three
years, possibly owing to the lack of
publishable progress and more
pressing clinical matters. 
In the ’30s, progress and insight
into the nature of the transforming
principle, as it came to be called,
was accompanied by efforts to
make a complex and chronically
troublesome assay simple and
stable. A primary problem was
contamination of the system by
what was later recognized to be
DNase; once recognized for its
relevance, DNase later proved a
critical tool for proving the identity
of the transforming principle. On
another front, efforts were made
to identify the serum factor
necessary to support in vitro
transformation. This was an
understandable goal, as the
standing protocol called for a
dose of heated chest fluids
obtained from patient samples.
Overall, according to McCarty,
during those years
“transformation in the test tube
remained an inconstant and
maddeningly unreliable process”.
In 1935 Avery and MacLeod had
yet to fully recognize that they
were dealing with a genetic
phenomenon — the
transformation seemed to be cast
in one report in terms of induced
systems of presumably extant, but
latent, synthetic enzymes. But that
year also saw a notable advance
in the finding that the transforming
principle survived chloroform
extraction, arguing against a
protein factor.
1940 marked a renewed effort,
and the investigators began to
appreciate an association between
the transforming principle and
nucleic acids in their preps. This
wasn’t an expected result. As
McCarty has written, ‘Knowledge
of the occurrence and distribution
of the nucleic acids in nature had
not yet reached the point where
one could assume that all living
cells contained both RNA and
DNA. Indeed, the notion had only
recently been discarded that there
were two general classes of
nucleic acid: plant nucleic acid…
and animal nucleic acids…’.
Despite growing evidence
equating DNA with the
transforming principle, it wasn’t
until the early ‘40s that the group
recognized that the shiny
precipitate they’d been observing
in their active preparations might
itself be DNA, and not
polysaccharide contaminant as
they had once assumed. Two
floors above, the protein
biochemist Alfred Mirsky had
succeeded in purifying a
nucleoprotein substance they
termed chromosin; through
interactions with Mirsky, Avery’s
group learned what purified DNA
looks like — fibrous, opalescent,
and quite different from the brown
powdery form with which they
were acquainted. And they
continued to gain valuable
evidence for DNA as the long-
sought factor: it absorbed UV light
at the right wavelengths, acted
like a very large molecule in a
centrifuge, and, most importantly,
was resistant to the right
enzymes. Altogether, the evidence
strongly pointed to the conclusion
that the activity lacked
demonstrable protein, saccharide,
or lipid, and was composed nearly
entirely of DNA.
They were aware they’d need to
build a strong case. Their upstairs
neighbor Mirksy was one of the
first skeptics, saying that the
transforming principle could not
possibly be DNA because “nucleic
acids are all alike”. This reflected a
widely held viewpoint generated
mainly by Pheobus Levene’s
tetranucleotide theory, which
essentially stated that the four
bases of DNA were joined together
in the same repeating order.
Clearly this idea wasn’t compatible
with DNA possessing much in the
way of biological specificity. In
reality, there was only very limited
evidence for the tetranucleotide
idea, and especially since DNA
was known to be closely
associated with chromosomes,
not everyone shared the view of its
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Oswald T. Avery: Born in Nova Scotia in
1877 to a Baptist minister, Avery prac-
ticed surgery in the early 1900s before
turning to bacteriology, where he broke
ground in his analysis of polysaccharide
capsules. A gifted speaker, he was
famous for monologues he’d deliver to
visitors and new associates on a range
of biological topics, but he was not fond
of delivering talks. To close associates
and friends he was known as ‘Fess’ – for
Professor, a title he never held. (Photo
courtesy of the Rockefeller University
Archives.)
Colin MacLeod: Also a minister’s son
born in Nova Scotia, MacLeod skipped
enough grades in school that McGill
asked that he stay back a year rather
than enter college at the age of fifteen.
After his work with Avery, he headed up
the New York University Department of
Bacteriology for fifteen years, later going
on to a career in science policy, working
for the War Department, the NIH, and the
National Academies. (Photo courtesy of
the Rockefeller University Archives.)
limited potential. But by and large,
Avery’s group would be working a
tough room. As Hotchkiss has
stated, “to recapture the state of
biochemical genetics around 1940,
one must think separately of the
biochemists’ genetic knowledge,
which was negligible, and of the
geneticists’ biochemical
knowledge, which, if sometimes
marked with great insight, was
mainly not functional”.
Avery exhibited a characteristic
reserve in putting the story on
record. The understated language
of the 1944 paper has been
suggested by some to evince a
lack of understanding on the part
of the authors for the significance
of their findings. But according to
McCarty, Avery “held to the
philosophy that it was enough to
present the facts and leave the
interpretations to others. It was
not that he was indifferent to the
interpretations, since he enjoyed
discussing them …but he was
more than reluctant to put his
speculation in writing for public
consumption”. This state of mind
is reflected in a letter Avery writes
at the time to his brother Roy, also
a bacteriologist. He reveals his
suspicions in tell-tale statements
(“Sounds like a virus — may be a
gene…”), but also asks Roy to be
discrete. “Talk it over with
[colleague] Goodpasture but don’t
shout it around — until we’re quite
sure or at least as sure as present
method permits. It’s hazardous to
go off half cocked — &
embarrassing to have to retract
later.” Nonetheless, from the letter,
and even his caution itself, it
seems clear Avery senses he’s
onto something big.
The appearance of the paper, in
Rockefeller’s Journal of
Experimental Medicine, wasn’t
marked by any notable events in
the way of scientific reception, but
circumstances wouldn’t have
favored it. Appearing four months
before D-day, the paper greeted
an audience that must have been
preoccupied with war (in fact the
war claimed two of the story’s
pioneers – Griffith perished in
London during the Blitz, and
Neufeld is thought to have starved
in 1945 Berlin). There was also the
difficulty posed by the fact that
geneticists did not generally read
JEM. This block effectively
symbolized the larger problem that
Avery’s group was up against,
namely a divide between
disciplines that seemed to barely
allow for the possibility that
serotype transformation of
bacteria could have anything to do
with the austere concepts of
classical genetics, and be
mediated by a chemical poorly
understood even by biochemists. 
The paper’s lack of visibility for
those who arguably needed most
to see it meant that its near-term
success was especially dependent
on word-of-mouth and vulnerable
to vocal criticism, particularly by
influential figures. As it happened,
Avery’s neighbor Mirsky became
the work’s chief public critic,
reiterating his conviction that
protein activity had not been
convincingly ruled out. Avery did
not feel the need to respond to
Mirsky, and generally eschewed
invitations to speak. Some of
these opportunities were passed
on to McCarty, but even at
meetings where sparks might have
flown – such as the 1946 Cold
Spring Harbor Symposium on
heredity and variation in
microorganisms where McCarty
spoke – they didn’t, at least in any
dramatic way.
But the paper was not ignored.
Ultimately, it was the investigators
who purposely set the course of
their own work in response to
Avery’s paper who brought about
acceptance of its ideas. Joshua
Lederberg, future president of
Rockefeller and a young graduate
student who had been greatly
impressed by the paper, based his
future work on it, and has
continued to be the paper’s
champion ever since. Arguably the
most critical positive influence was
that of Erwin Chargaff, who turned
his biochemical work to a
wholesale effort aimed at
understanding amino acids in an
enterprise that finally overturned
the tetranucleotide hypothesis and
cleared the way for acceptance of
DNA’s specificity. Forming a
bridge between two great
discoveries, Chargaff’s
subsequent work on base
composition provided a much-
needed clue to Watson and Crick. 
Despite missing out on a Nobel
prize, Avery did receive
recognition for his work; in
particular, the Copley Medal from
the Royal Society, which he
received in 1946, is seen as the
first official recognition of his
achievement. The conservative
nature of Nobel awarding did not
work in Avery’s favor, especially as
he was already in his mid-sixties
when the 1944 paper was
published. The ideas needed time
to be accepted, and for many that
didn’t occur until Hershey and
Chase’s work on phage DNA
transmission in 1952, and Watson
and Crick’s paper the following
year. There was time for Avery to
receive a Nobel even after these
discoveries, but it was not to be,
and he died in 1955.
If it was indeed Watson and
Crick’s ringing proclamation in
1953 that made the Avery
discovery believable to straggling
doubters, it serves to illustrate that
not all revolutions in biology are
quiet. But thanks to a missing
prize, Avery’s legacy may be a
more willing audience in biology
for quiet revolutions still finding
their voice.
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Maclyn McCarty: Born in South Bend,
Indiana, ‘Mac’ was guided by well-read
parents and formed an ‘Amateur
Research Chemists’ club with friends in
high school. He studied medicine and
was a pediatrics intern before joining
Avery’s group. Following the transforma-
tion work, he switched to the study of
rheumatic fever, and remained on the
faculty at Rockefeller — as did Mirsky,
with whom he was admirably able to
foster a civil relationship. Now in his 90s,
McCarty is Professor Emeritus at Rocke-
feller. (Photo courtesy of the Rockefeller
University Archives.)
